Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate for the Treatment of Uncomplicated Falciparum Malaria in Children: A Multisite, Open-label, Two-cohort Clinical Trial in Mozambique.

NCT02168569 is registered in ClinicalTrials.gov with Centro de Investigacao em Saude de Manhica as lead sponsor.

NCT NCT02168569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02168569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate for the Treatment of Uncomplicated Falciparum Malaria in Children: A Multisite, Open-label, Two-cohort Clinical Trial in Mozambique.
Lead sponsor
Centro de Investigacao em Saude de Manhica
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2011
Completion date
January 31, 2013
Enrollment
700 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

malaria